Testing effectiveness (Phase 2)Ended earlyNCT02088060
What this trial is testing
A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients
Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 150